Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.

Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory ...

The average human has about 1.8 trillion immune cells. These cells patrol the body for bacteria, viruses, cancers, and other ...

Eli Lilly's $7 billion deal for Kelonia Therapeutics on Monday was just the latest example | Despite the recent “feeding ...

New research defines RSV viral shedding timelines, showing a short infectious window and key immune responses to guide prevention.

Eradivir Inc., a clinical-stage biotech company developing antibody-recruiting small molecules to treat disease, today ...

Enflonsia is contraindicated in infants with hypersensitivity to its active substance or excipients.

Doha: The Ministry of Public Health (MoPH) has announced the vaccination requirements for Hajj 1447H/2026, reaffirming its ...

HZI project ENDURIVAC develops innovative long-acting vaccine against respiratory pathogens According to estimates by the World Health Organization (WHO), vaccinations have saved more than 150 million ...

AI predicted that a forgotten breast cancer drug could be repurposed to treat many respiratory and gastrointestinal viruses, and subsequent animal tests suggests it may be right ...